Domů › Rakovina prsu › Missouri › St. Louis
Klinické studie Rakovina prsu v St. Louis, MO
64 studií pro Rakovina prsu hledá účastníky v lokalitách v St. Louis a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- Washington University School of Medicine, St Louis
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Probíhá náborFáze 3
- Washington University School of Medicine- Siteman Cancer Center, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- a dalších 4
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Washington University, School of Medicine, St Louis
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Probíhá náborFáze 1
- Washington University School of Medicine, St Louis
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Probíhá náborFáze 1
- Washington University in St Louis, St Louis
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Probíhá náborFáze 3
- Washington University School of Medicine ( Site 0076), St Louis
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Probíhá náborFáze 3
- Research Site, St Louis
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Probíhá náborFáze 2
- Washington University School of Medicine- Siteman Cancer Center, St Louis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Probíhá náborFáze 3
- Washington University Siteman Cancer Center ( Site 0031), St Louis
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Local Institution - 0140, St Louis
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Probíhá nábor
- Mercy Health - Sindelar Cancer Center, St Louis
- Mercy Health - Pratt Cancer Center, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Probíhá náborFáze 1
- Washington University, St Louis
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Probíhá náborFáze 1
- Washington University School of Medicine in St. Louis, St Louis
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Probíhá náborFáze 1/2
- Washington University School of Medicine, St Louis
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Probíhá náborFáze 3
- Cancer Care Specialists of Illinois, O'Fallon · Vzdálenost 16 mi
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Probíhá náborFáze 1/2
- Washington Univ. School of Medicine, St Louis
Precision Supplemental Imaging in Women With Dense Breasts
Probíhá náborVítáni zdraví dobrovolníci
- Washington University School of Medicine, St Louis
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Probíhá náborFáze 3
- Siteman Cancer Center, St Louis
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Probíhá náborFáze 1/2
- Research Site, St Louis
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- Washington University School of Medicine, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- Washington University School of Medicine, St Louis
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Probíhá náborFáze 1
- Washington University Medical School, St Louis
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Probíhá náborFáze 1/2
- Washington University Siteman Cancer Center, St Louis
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Probíhá náborFáze 3
- Cancer Care Specialists of Central Illinois, O'Fallon · Vzdálenost 16 mi
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Probíhá náborObservační studie
- Cancer Care Specialist of Illinois, O'Fallon · Vzdálenost 16 mi
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Probíhá náborObservační studie
- Washington University School of Medicine, St Louis
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Probíhá náborFáze 3
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- a dalších 9
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Probíhá náborFáze 1
- Washington University, St Louis
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Probíhá náborFáze 1/2
- WA Uni School Of Med, St Louis
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- Washington University School of Medicine - Siteman Cancer Center, St Louis
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Probíhá náborFáze 1
- Washington University, Siteman Cancer Center, St Louis
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Probíhá náborFáze 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- a dalších 4
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Probíhá náborFáze 1
- Washington University School of Medicine, St Louis
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Probíhá náborFáze 3
- Siteman Cancer Center - Washington University Medical Campus, St Louis
IDOV-Immune for Advanced Solid Tumors
Probíhá náborFáze 1
- Washington University School of Medicine, St Louis
E-Mindfulness Approaches for Living After Breast Cancer
Probíhá náborFáze 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · Vzdálenost 16 mi
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- Investigative Site #110, St Louis
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Probíhá náborFáze 1
- Washington University School of Medicine, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Washington University, St Louis
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
Probíhá nábor
- Washington University School of Medicine, St Louis
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Probíhá náborFáze 3
- Washington University School of Medicine, St Louis
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
Probíhá nábor
- Washington University School of Medicine, St Louis
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Probíhá náborFáze 3
- Washington University School of Medicine in Saint Louis, St Louis
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
Probíhá náborObservační studie
- Washington University School of Medicine, St Louis
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Probíhá náborFáze 3
- Siteman Cancer Center, St Louis
- Siteman Cancer Center - North County, Florissant · Vzdálenost 13 mi
- Memorial Hospital., Shiloh · Vzdálenost 17 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Probíhá náborFáze 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- a dalších 3
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Probíhá náborFáze 1/2
- Washington University School of Medicine, St Louis
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Probíhá náborObservační studie
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- a dalších 4
Cryoablation vs Lumpectomy in T1 Breast Cancers
Probíhá nábor
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Washington University School of Medicine, St Louis
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
Probíhá nábor
- Washington University School of Medicine, St Louis
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Probíhá náborObservační studie
- Washington University School of Medicine, St Louis
WashU DIEP Flap Video and Patient Understanding Improvement
Probíhá nábor
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, St Louis
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Probíhá náborFáze 3
- Saint Louis Cancer and Breast Institute-South City, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- a dalších 2
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Probíhá náborFáze 1
- Washington University School of Medicine St. Louis, St Louis
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Probíhá náborObservační studie
- Washington University School of Medicine, St Louis
Studie Rakovina prsu v jiných městech
- New York City, NY136 studií
- Houston, TX126 studií
- Boston, MA112 studií
- Nashville, TN81 studií
- Los Angeles, CA73 studií
- Edison, NJ68 studií
- Queens, NY64 studií
- Durham, NC64 studií
- Chicago, IL59 studií
- Philadelphia, PA56 studií
- Dallas, TX55 studií
- Arlington, VA47 studií
Další studie v St. Louis
- Nemalobuněčný plicní karcinom73 studií
- Metastatický karcinom54 studií
- Kolorektální karcinom50 studií
- Rakovina (všechny typy)46 studií
- Rakovina prostaty46 studií
- Rakovina plic39 studií
- Rakovina vaječníků38 studií
- Rakovina slinivky břišní33 studií
- Rakovina endometria29 studií
- Squamózní buněčný karcinom hlavy a krku28 studií
- Srdeční selhání26 studií
- Obesity25 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.